Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1215 results for "ranbaxy"

Daiichi Sankyo plans to sell 9% stake in Sun Pharma
India Infoline

Daiichi Sankyo's disastrous India foray with hybrid model

Senior Editor, PB Jayakumar Eight years after making its India foray through the acquisition of Ranbaxy Laboratories, Japan's second-largest drug company Daiichi Sankyo is leaving the Indian shores with lots of losses and bitter experiences. When ... Business Today India, 39 minutes ago
Daiichi Sankyo to sell stake in Sun Pharma Business Standard, 1 day ago
India Infoline

Cipla, Ranbaxy and Biocon adopt Cirrius PharmaCRM platform

The platform rides on three components, the base CRM platform, Closed Loop Marketing and the Phyzii engagement platform that fuels effective interactions between pharmaceutical companies and their network of medical reps, physicians, patients and the supply ...
 India Infoline4 hours ago Pharma companies adopt Cirrius PharmaCRM platform on Microsoft azure to streamline medical engagements  Dataquest1 hour ago
Business Standard

Sun Pharma drops after listing of shares allotted to Ranbaxy shareholders

Sun Pharmaceutical Industries fell 1.64% to Rs 1,071.70 at 11:04 IST on BSE after shares allotted to shareholders of Ranbaxy Laboratories on merger were admitted for trading on the bourses today, 17 April 2015. Meanwhile, the S&P BSE Sensex ...
 Capital Market4 days ago Sun Pharma dips on listing of new shares  Business Standard4 days ago Sun Pharma Board approves allotment of 33.49 Cr equity shares to Ranbaxy Shareholders  India Infoline1 week ago Ranbaxy Laboratories allots equity shares  Business Standard2 months ago

Ranbaxy recalls one batch of epilepsy drug, RAN-gabpentin from Canadian market

Ranbaxy Pharmaceuticals Canada Inc., a subsidiary of Ranabxy Laboratories, has recalled one batch of RAN-gabapentin, a medication used to treat epilepsy, (RAN-gabapentin capsules 100 mg, batch no 2582026, expiry date December 2015) from Canadian ...
 PharmaBiz1 week ago Ranbaxy Pharmaceuticals Canada Release: Recall Of One Batch Of RAN-Gabapentin 100 Mg Capsules Due To Cross-Contamination With Etodolac 4/10/2015  ClinicSpace1 week ago Advisory - Recall of one batch of RAN-Gabapentin 100 mg capsules due to cross-contamination with Etodolac  Wall Street Select1 week ago Recall of one batch of RAN-Gabapentin 100 mg capsules due to cross-contamination with Etodolac  Health Canada1 week ago

Hold Reliance Industries; target Rs 980: Gaurang Shah

G "In Ranbaxy Laboratories , the merger process is already through with Sun Pharma . As a disclosure we do have positive coverage on both. Normally it takes anything between a month to 45 days time for all the approvals and procedural things to go ...
 Moneycontrol.com1 week ago

Lifeline ends for Ranbaxy after half-a-century existence

The Gurgaon-based company has been suspended from trading on the bourses on Monday due to procedural reasons, resulting in its delisting exactly one year after Dilip Shanghvi-owned Sun Pharmaceutical Industries agreed to buy the company from its Japanese ...
 DNA2 weeks ago

Ranbaxy's stock market stint

Ranbaxy Laboratories was started in 1937 as a small medicine-distribution business in Amritsar by Ranjit Singh and Gurbax Singh. In 1952, Bhai Mohan Singh became the promoter of the company. The firm was officially incorporated in 1961 and went ...
 Livemint.com2 weeks ago
Nikkei Asian Review

Ranbaxy fades into sunset

Sun Pharma to focus on integration, open to more acquisitions
 DNA3 weeks ago India's Sun Pharmaceutical Closes USD 4bn Merger with Ranbaxy  Bloomberg3 weeks ago Sun Pharma wraps up Ranbaxy deal  Nikkei Asian Review3 weeks ago India's Sun Pharma open to large acquisitions post Ranbaxy deal  Reuters UK3 weeks ago
Money Today

Ranbaxy stock to stop trading on exchanges from next week

Pic Courtesy: - Zee Media BureauShares of Ranbaxy Laboratories will stop trading on BSE and NSE with effect from Monday (April 6) onwards as the company is merging with Sun Pharmaceutical Industries in a USD 4 billion deal. Sun Pharma would be ...
 ZeeNews.com2 weeks ago Ranbaxy: April 1 set as last day for trading  Hindu Business Line3 weeks ago Ranbaxy Shares to Stop Trading on Exchanges From April 6  New Indian Express3 weeks ago Ranbaxy Shares to Stop Trading on Bourses From April 6  NDTV Profit3 weeks ago

Sell Ranbaxy with a target of Rs 785: Sandeep Wagle

Comments are moderated and will be allowed if they are about the topic and not abusive. Characters remaining ( 1500 ) To post this comment you must Log In/Connect with: Indiatimes Network or Fill in your details: Will be displayed Will not be displayed Will ...
 Economic Times3 weeks ago Buy Ranbaxy Labs with a target of Rs 814: Sandeep Wagle.  Economic Times1 month ago Buy Ranbaxy with a target of Rs 850: Prakash Gaba  Economic Times1 month ago Buy Ranbaxy with a target of Rs 755: Sandeep Wagle  Economic Times2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy
Get updated on latest news & your favorite topics right in your inbox!
More     Less